Transaction Details
- Date: September 11, 2026
- Entity: Dr. Krishna Prasad Chigurupati, Promoter of Granules India Limited
- Transaction Type: Sale of equity shares through block deal and open market
- Quantity Sold: 1,72,00,000 (1.72 crore) equity shares
- Investor Participation: Marquee institutional investors including Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, Allspring, and other domestic and global investors
Purpose of Transaction
The transaction was undertaken to fund the second tranche of the Company's ongoing preferential issue and support the next phase of growth initiatives in line with its stated objects.
Funds Utilization Update
The Company has deployed the funds raised through the preferential issue in February 2026 and executed the identified growth initiatives at a pace faster than originally envisaged. The funds have been utilized significantly earlier than anticipated, reflecting the Company's focused execution of its strategic growth plans. The utilization remains fully aligned with the objects disclosed at the time of the preferential issue.
Shareholding Impact
Pre-Transaction Shareholding:
- Promoter and Promoter Group aggregate: 38.02% of paid-up equity share capital
- Dr. Krishna Prasad Chigurupati individual: 31.00% of paid-up equity share capital
Post-Transaction Shareholding:
- Promoter and Promoter Group aggregate: 31.08% of paid-up equity share capital
- Promoter and Promoter Group aggregate (diluted basis): 37.39%
- Dr. Krishna Prasad Chigurupati individual: 24.06% of paid-up equity share capital